AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10916110
Drug: Intravenous folic
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous folic acid (10 mg posthemodialysis, 30 mg per week)
Trial: 8873685
Drug: Rifampin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (300 mg b.i.d. for 7 days)
Trial: 8873685
Drug: Erythromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (250 mg q.i.d. for 7 days)
Trial: 1647387
Drug: Interactive information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive information system with instructional video programs, feedback on purchases, specific goals for change, weekly programs, and tracking user interactions; duration: 7-8 weeks intervention phase after a 5-7 week baseline phase.
Trial: 27287439
Drug: Ovaleap® (recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ovaleap® (recombinant human follicle-stimulating hormone) administered for up to 2 additional cycles
Trial: 8953337
Drug: 6.9% glucose-polymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.9% glucose-polymer (GP) solution
Trial: 17135583
Drug: Episodic use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Episodic use of antiretroviral therapy (drug conservation group)
Trial: 17135583
Drug: Continuous use
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous use of antiretroviral therapy (viral suppression group)
Trial: 8835583
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of rifampicin
Trial: 8835583
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of rifampicin
Trial: 23602244
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (37.4 mg of elemental iron daily for 12 weeks)
Trial: 21747102
Drug: No pills
RxNorm normalized name: No Doz Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pills
Trial: 21747102
Drug: Blinded to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blinded to placebo vs No pills
Trial: 21747102
Drug: Subgroup (rated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgroup (rated echinacea's effectiveness >50) - Blinded to placebo vs No pills
Trial: 21437714
Drug: almotriptan 12.5
RxNorm normalized name: almotriptan 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: almotriptan 12.5 mg
Trial: 15611510
Drug: Doxorubicin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 60 mg/m² plus paclitaxel 200 mg/m² (AP)
Trial: 11426769
Drug: Bovine and
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bovine and porcine heparin
Trial: 7744133
Drug: Diclofenac/misoprostol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac/misoprostol (50 mg/200 mcg) administered BID or TID (n = 177)
Trial: 7744133
Drug: Diclofenac/placebo (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac/placebo (50 mg) administered BID or TID (n = 169)
Trial: 4936538
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with phenothiazines
Trial: 22243938
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline solution (HSS) 100mL (NaCl 7.5%) twice daily for three days
Trial: 18838979
Drug: High-Ca diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Ca diet (2300 mg Ca per d)
Trial: 18838979
Drug: Low-Ca diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Ca diet (700 mg Ca per d)
Trial: 12705061
Drug: Selective cyclooxygenase-2
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selective cyclooxygenase-2 inhibitors (e.g., celecoxib, rofecoxib, parecoxib)
Trial: 12705061
Drug: Classic non-steroidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classic non-steroidal anti-inflammatory drugs (e.g., ibuprofen, naproxen)
Trial: 8292679
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage (2.25 T)
Trial: 2853164
Drug: Granular porous
RxNorm normalized name: Saxifraga granulata whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granular porous hydroxylapatite implants
Trial: 2853164
Drug: Solid porous
RxNorm normalized name: Corydalis solida whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solid porous hydroxylapatite implants
Trial: 31490817
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at 1 µg/mL (group P1)
Trial: 31490817
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at 2 µg/mL (group P2)
Trial: 31490817
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at 3 µg/mL (group P3)
Trial: 31490817
Drug: Propofol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1 to 3 µg/mL)
Trial: 22248760
Drug: Epidural S(+)-ketamine
RxNorm normalized name: (S)-(-)-ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural S(+)-ketamine with 0.25% bupivacaine (13 mL + 25 mg) before incision
Trial: 22248760
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution before incision followed by epidural S(+)-ketamine with 0.25% bupivacaine (13 mL + 25 mg) after incision
Trial: 16284537
Drug: Preventive HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive HIV vaccine trial
Trial: 9789590
Drug: Glimepiride, Repaglinide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride, Repaglinide, Glucagon-like peptide I (drugs stimulating insulin secretion)
Trial: 9789590
Drug: Thiazolidinediones (medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazolidinediones (medications reducing insulin resistance)
Trial: 9789590
Drug: Vanadium (insulin-mimetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vanadium (insulin-mimetic agents)
Trial: 9789590
Drug: Alpha glucosidase
RxNorm normalized name: alpha glucosidase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha glucosidase inhibitors
Trial: 30793734
Drug: Dabigatran dual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran dual therapy
Trial: 19341987
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate 15mg/day capsules
Trial: 17298975
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DES) in small stents/bypass grafts
Trial: 17298975
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DES) in other patients
Trial: 12791056
Drug: Insecticide-treated synthetic-netting
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insecticide-treated synthetic-netting ceiling (deltamethrin 12.5 mg/m2)
Trial: 10522581
Drug: Ropivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 7.5 mg x ml(‐1)
Trial: 10522581
Drug: Bupivacaine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 5.0 mg x ml(‐1)
Trial: 1723814
Drug: Alfuzosine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosine 2.5 mg x 3
Trial: 7048251
Drug: Captopril-labetalol combination
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril-labetalol combination treatment
Trial: 25278227
Drug: Nine-valent human
RxNorm normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nine-valent human papillomavirus vaccine (selected dose formulation)
Trial: 25278227
Drug: Four-valent human
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-valent human papillomavirus vaccine (active control)
Trial: 25278227
Drug: Four-valent human
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-valent human papillomavirus vaccine
Trial: 16776928
Drug: Midazolam (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (7.5 ‐ 15 mg before sleep, n = 113)
Trial: 16776928
Drug: Estazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estazolam (1 ‐ 2 mg before sleep, n = 104)
Trial: 10856535
Drug: Atorvastatin 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 120 mg/day
Trial: 10856535
Drug: Atorvastatin 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 160 mg/day
Trial: 9021345
Drug: Agnus castus
RxNorm normalized name: Vitex agnus-castus whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agnus castus extract (BP1095E1) 120 mg/day
Trial: 9021345
Drug: Agnus castus
RxNorm normalized name: Vitex agnus-castus whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agnus castus extract (BP1095E1) 240 mg/day
Trial: 9021345
Drug: Agnus castus
RxNorm normalized name: Vitex agnus-castus whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agnus castus extract (BP1095E1) 480 mg/day
Trial: 2676121
Drug: Verapamil (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (320 mg/day)
Trial: 28891027
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate monohydrate 3 mg/kg twice a day orally for 10 days along with standard antibiotics
Trial: 28891027
Drug: No zinc
RxNorm normalized name: ZINC OXIDE 140 mg in 1 mL TOPICAL CREAM [Lucin Organics Tinted Sunscreen SPF 30 Non Nano Zinc Oxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No zinc (antibiotic treatment only)
Trial: 20798191
Drug: Sunscreen with
RxNorm normalized name: ZINC OXIDE 0.1995 g in 1 g TOPICAL CREAM [SilkShield All Mineral Sunscreen with TriHex Technology]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunscreen with SPF 60 applied twice a day for 28 days
Trial: 16983914
Drug: Shenmai Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenmai Injection (SMI) 30 ml once a day for 10 days
Trial: 16983914
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy plus NPPV (Control)
Trial: 12452216
Drug: Sufentanil 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 0.5 microg/kg administered prior to skin incision, median sternotomy, CPB, and after coming off CPB
Trial: 12452216
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 mg/kg administered at the same time periods as sufentanil
Trial: 10626336
Drug: Movalis 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Movalis 7.5 mg
Trial: 10626336
Drug: Movalis 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Movalis 15 mg
Trial: 10626336
Drug: Movalis (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Movalis (dose increased from 7.5 mg to 15 mg in poor responders)
Trial: 1981434
Drug: Active grenz
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active grenz ray therapy (4 Gy, 10 kV, applied 6 times at 1-week intervals)
Trial: 1981434
Drug: Stimulated therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulated therapy (control)
Trial: 6757467
Drug: Bacillus Calmette‐Guerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette‐Guerin (BCG) immunotherapy
Trial: 25338776
Drug: Imipramine or
RxNorm normalized name: imipramine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine or venlafaxine (antidepressants)
Trial: 24518937
Drug: Gabapentin 300
RxNorm normalized name: gabapentin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 300 mg orally 2 hours before surgery and 12.5 mg of heavy bupivacaine 0.5% intrathecally
Trial: 24518937
Drug: Intrathecal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal fentanyl 10 μg plus 12.5 mg of heavy bupivacaine 0.5%
Trial: 17519078
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with Alutard SQ (ASQ)
Trial: 31994278
Drug: Nutraceutical compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutraceutical compound containing Ilex paraguariensis, White Mulberry and Chromium Picolinate (500 mg), taken once a day for 3 months.
Trial: 19933412
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (GTN; 0.6 mg/h) for 2 hours on 1 day only
Trial: 19933412
Drug: Transdermal GTN
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal GTN for 2 hours/day for 7 days
Trial: 19933412
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy with transdermal GTN for 7 days
Trial: 19933412
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion of vitamin C after continuous GTN therapy
Trial: 12903463
Drug: Gossypol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gossypol (15 mg/d for 12 weeks, then 10 mg/d for 32 weeks)
Trial: 9333168
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (2 mL of 720 ELISA units/mL) given to HIV-infected men either 1 or 6 months apart; HIV-uninfected men received vaccine at study entry and at 6 months.
Trial: 3096634
Drug: Levonorgestrel and
RxNorm normalized name: levonorgestrel and estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel and Ethinyl Estradiol as an oral tablet
Trial: 3096634
Drug: Levonorgestrel and
RxNorm normalized name: levonorgestrel and estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel and Ethinyl Estradiol as a solution
Trial: 3407613
Drug: Intrinsically labeled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrinsically labeled beef (100 g)
Trial: 3407613
Drug: Extrinsically labeled
RxNorm normalized name: Ga-68-Labeled PSMA-11
DrugBank: Gallium Ga-68 gozetotide (DB16019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extrinsically labeled beef (100 g)
Trial: 28526377
Drug: OJ group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OJ group (500 mL/d of 100% orange juice)
Trial: 24334780
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with an additional escalating reinforcement scheme (n = 72)
Trial: 24334780
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (n = 64)
Trial: 19182698
Drug: 10 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g/day of MF101
Trial: 19182698
Drug: 5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g/day of MF101
Trial: 12453926
Drug: Codeine 1.5
RxNorm normalized name: codeine 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine 1.5 mg kg(‐1)
Trial: 10892897
Drug: Liseta (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liseta (150 microg desogestrel and 1.5 mg 17beta‐estradiol)
Trial: 10892897
Drug: Intravenous dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dose of 150 microg etonogestrel
Trial: 10892897
Drug: Cerazette (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerazette (multiple dosing, 1 tablet once daily for 7 days)
Trial: 10892897
Drug: Cerazette (single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerazette (single-dose treatments)
Trial: 14502085
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg haloperidol (dopaminergic D2 receptor antagonist)
Trial: 11300369
Drug: Perindopril (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (8 mg for 12 months)
Trial: 8982289
Drug: conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional chemotherapy (C.CHE) + rHuG‐CSF
Trial: 8982289
Drug: high dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high dose cytoxan (HD.CTX) + rHuG‐CSF
Trial: 30575407
Drug: Amphetamine extended-release
RxNorm normalized name: amphetamine Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amphetamine extended-release oral suspension (AMPH EROS) 15, 17.5, or 20 mg
Trial: 29063518
Drug: ALZ-801 (265
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALZ-801 (265 mg twice daily)
Trial: 29063518
Drug: Immediate-release tablet
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release tablet formulation of ALZ-801
Trial: 26842771
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g freeze-dried whole strawberry powder (FDS)
Trial: 26842771
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g freeze-dried whole strawberry powder (FDS)
Trial: 26842771
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g freeze-dried whole strawberry powder (FDS)
Trial: 26842771
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g freeze-dried whole strawberry powder (FDS, control)
Trial: 20148270
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ESAs and parenteral iron
Trial: 14533837
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg on day 1, followed by 250 mg once a day on days 2 to 5)
Trial: 14533837
Drug: Cefadroxil (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil (500 mg twice a day for 10 days)
Trial: 10779658
Drug: Capsaicin injection
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin injection (50 microg)
Trial: 10779658
Drug: Controlled-force stimuli
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-force stimuli (16, 32, and 64 g) applied via a 12-mm wide, 100-microm thick blade probe
Trial: 10779658
Drug: Hand-held 20-g
RxNorm normalized name: lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hand-held 20-g von Frey probe
Trial: 1529745
Drug: des‐enkephalin‐gamma‐endorphin (DE‐gamma‐E)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: des‐enkephalin‐gamma‐endorphin (DE‐gamma‐E) 10 mg given as a once daily intramuscular injection for 4 weeks
Trial: 1529745
Drug: thioridazine 400
RxNorm normalized name: Thioridazine
DrugBank: Thioridazine (DB00679)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: thioridazine 400 mg orally in 2 divided doses
Trial: 24414607
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D 1,000 IU/day and elemental calcium 500 mg/day
Trial: 24414607
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D and calcium co-administration
Trial: 18506735
Drug: Norfloxacin formulation
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin formulation 1
Trial: 18506735
Drug: Norfloxacin formulation
RxNorm normalized name: Norfloxacin
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin formulation 2
Trial: 15947511
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour group therapy (CBGT), 12 two-hour sessions over 6 months
Trial: 12853808
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 or 2 x 0.4 mg daily)
Trial: 10601507
Drug: Electrophysiologically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrophysiologically guided antiarrhythmic therapy (including drugs and implantable defibrillators)
Trial: 10601507
Drug: Defibrillator treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrillator treatment